HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma
Methodology, Interpretation, and Significance
Click CC to turn on closed captioning.
Human papillomavirus (HPV) is detected in 50% to 80% of oropharyngeal squamous cell carcinomas (OPSCCs). Dr. García describes the various testing methods for HPV detection, including DNA in situ hybridization (ISH), polymerase chain reaction (PCR), p16 immunochemistry, and E6/E7 messenger ribonucleic acid (mRNA). He also discusses the interpretation and significance of the assay results.
- Joaquín García, MD
- Consultant, Division of Anatomic Pathology
- Assistant Professor of Laboratory Med/Pathology, College of Medicine
HPV Hot Topics
- Hot Topic: Cervical Cytology and HPV Testing - What's New and What You Need to Know
- Hot Topic: HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma
- Hot Topic: Human Papillomavirus Molecular Detection with Genotyping
- Hot Topic: HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma: Indication, Interpretation, and Implication
- 80172 Human Papillomavirus (HPV) Typing In Situ DNA Hybridization
- 5439 Surgical Pathology Consultation
- 60483 Human Papillomavirus (HPV), High-Risk DNA Detection Only, In Situ DNA Hybridization
Forward to a Colleague
Share this presentation with:
If you have questions, email .